Why investors don't need to be nervous about a stretched stock market in 2025: Strategist
"It comes down to the following surprise: there is a lot less leverage in the stock market" a ProShares analyst told Bloomberg.
Apple stock has 26% upside as its AI strategy unlocks a 'new era' of growth, Wedbush says
Dan Ives' supply chain checks indicate that consumers like Apple's AI strategy, suggesting that the iPhone 16 cycle could be "a historical one."
Stock market today: Indexes slip as bond yields disrupt holiday gains
Stocks pulled back after holiday gains as investors adjusted to a mixed jobless claims print.
SEALSQ Corp Regains Nasdaq Compliance, Strengthening Market Position
SEALSQ Corp ( (LAES) ) has shared an announcement. SEALSQ Corp has regained compliance with Nasdaq’s minimum bid price requirement, securing its position on the stock market. This achievement reflects the company’s closing bid price of at least $1.00 for 10 consecutive business days, leading to the closure of the compliance matter by Nasdaq. This development is significant for SEALSQ as it maintains its market presence and reassures stakeholders of its stability and adherence to listing standard
Bitcoin holds steady near $95,000, eyes $200,000 target by mid-2025
The cryptocurrency has pulled back since topping $108,000 earlier this month.
Trump's first actions and job data to test market in January
NEW YORK (Reuters) -After closing the books on a banner year for U.S. stocks, investors expect to ride seasonal momentum into mid-January when a slew of economic data and a transition of power in Washington could send markets moving. The S&P 500 rose roughly 25% in 2024 through Dec. 27, while the technology-heavy Nasdaq Composite index <.IXIC >, which surpassed 20,000 for the first time in December, is up over 31%. "There are concerns that maybe the first part of (next) year can involve some repositioning and reallocation of funds and those that are trading today and next week are probably just trying to get a little bit ahead of that," said Robert Pavlik, senior portfolio manager at Dakota Wealth.
Ingles Markets Faces Nasdaq Filing Delay Due to Hurricane
Ingles Markets ( (IMKTA) ) has issued an announcement. Ingles Markets announced that it received a notice from Nasdaq due to a delay in filing its Annual Report for the fiscal year ending September 28, 2024. The delay, attributed to the impact of Hurricane Helene, has not affected the immediate Nasdaq listing of its Class A Common Stock. The company has until February 18, 2025, to comply with Nasdaq’s filing requirements or submit a compliance plan. Ingles Markets intends to file the report with
Elite Pharmaceuticals Launches Generic Vyvanse for ADHD Market
Elite Pharmaceuticals ( (ELTP) ) has issued an update. Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting the ADHD treatment market. The product, which is marketed under the Elite Laboratories, Inc. label, is expected to capture a portion of the $4.3 billion annual sales reported by IQVIA for the original product, potentially enhancing Elite’s market presence in the generic pharmaceutical industry. More about
Bitcoin rally runs out of steam, currency fights to reclaim $100,000
The history of Bitcoin, which is down 14%, is helpful in trying to predict what will happen next.
The stock market slumped today. Why is the 'Santa rally' over?
Investors became gloomy on Friday, threatening to derail a long winning streak for stocks, as inflation remained high.